Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights
- PMID: 12044538
- DOI: 10.1016/s0168-8278(02)00042-9
Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights
Abstract
Aceruloplasminemia is an autosomal recessive disease of iron overload associated with mutation(s) in the ceruloplasmin gene. We report here a new case of aceruloplasminemia in a woman who is a compound heterozygote for two new mutations. Besides this novel genotypic profile, this observation provides new insights on: (i) iron metabolism with normal erythroid repartition, in the absence of serum non-transferrin-bound iron and with an increase of 59Fe plasma clearance; (ii) hepatic abnormalities associated with the presence of iron-free foci; (iii) the therapeutic management of the disease, chronic subcutaneous infusion of deferrioxamine being remarkably effective at reducing hepatic iron overload.
Similar articles
-
Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.J Hepatol. 2010 Dec;53(6):1101-7. doi: 10.1016/j.jhep.2010.04.039. Epub 2010 Aug 4. J Hepatol. 2010. PMID: 20801540 Free PMC article.
-
Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations.Blood. 2002 Sep 15;100(6):2246-8. doi: 10.1182/blood-2002-02-0584. Blood. 2002. PMID: 12200392
-
Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia?Blood Cells Mol Dis. 2016 Mar;57:112-4. doi: 10.1016/j.bcmd.2015.12.011. Epub 2015 Dec 30. Blood Cells Mol Dis. 2016. PMID: 26777753 No abstract available.
-
[Aceruloplasminemia, a rare condition not to be overlooked].Rev Med Interne. 2020 Nov;41(11):769-775. doi: 10.1016/j.revmed.2020.06.002. Epub 2020 Jul 16. Rev Med Interne. 2020. PMID: 32682623 Review. French.
-
Aceruloplasminemia.Pediatr Res. 1998 Sep;44(3):271-6. doi: 10.1203/00006450-199809000-00001. Pediatr Res. 1998. PMID: 9727700 Review.
Cited by
-
T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation.Neurology. 2008 Apr 29;70(18):1614-9. doi: 10.1212/01.wnl.0000310985.40011.d6. Neurology. 2008. PMID: 18443312 Free PMC article.
-
Iron, hepcidin, and the metal connection.Front Pharmacol. 2014 Jun 4;5:128. doi: 10.3389/fphar.2014.00128. eCollection 2014. Front Pharmacol. 2014. PMID: 24926268 Free PMC article. Review.
-
Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders.Front Neurol. 2021 Apr 15;12:629414. doi: 10.3389/fneur.2021.629414. eCollection 2021. Front Neurol. 2021. PMID: 33935938 Free PMC article. Review.
-
Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.J Hepatol. 2010 Dec;53(6):1101-7. doi: 10.1016/j.jhep.2010.04.039. Epub 2010 Aug 4. J Hepatol. 2010. PMID: 20801540 Free PMC article.
-
Aceruloplasminemia: Waiting for an Efficient Therapy.Front Neurosci. 2018 Dec 4;12:903. doi: 10.3389/fnins.2018.00903. eCollection 2018. Front Neurosci. 2018. PMID: 30568573 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources